Fatty acids could lead to flu drug

March 7, 2013, Cell Press

Flu viruses are a major cause of death and sickness around the world, and antiviral drugs currently do not protect the most seriously ill patients. A study published March 7th by Cell Press in the journal Cell reveals that a compound derived from fats found in fish oils prevents death in influenza-virus-infected mice, even at advanced stages of disease. The study offers a promising strategy for the treatment of patients with severe influenza virus infections.

"Given the potential for future lethal pandemics, effective drugs are needed for the treatment of severe influenza, such as that caused by H5N1 viruses," says senior study author Yumiko Imai of Akita University. "We have identified a novel for the treatment of severe influenza that is effective under conditions where known antiviral drugs fail to protect from death."

Currently available antiviral drugs inhibit influenza , but they are not typically effective when given to patients as little as 2 days after infection. In an attempt to discover more effective drug targets for influenza, scientists have recently identified several genes and molecules that are crucial for influenza virus replication. However, until now it was not known whether naturally occurring lipids, such as those derived from omega-3 (PUFAs) found in fish oils, might also be involved in influenza virus infections.

To answer this question, Imai and her team screened for PUFA-derived lipids in influenza-virus-infected human lung cells. When they treated infected cells with these lipids, they found that protectin D1 (PD1) was the most effective at inhibiting the replication of viruses, including H5N1.

In addition, low levels of PD1 in the lungs of influenza-virus-infected mice were associated with severe infection and highly pathogenic viruses, such as H5N1. Treatment with PD1 in combination with an approved antiviral drug improved the survival of influenza-virus-infected mice and prevented death, even when given 2 days after infection. "Our findings suggest that PD1could serve as a biomarker as well as a much needed antiviral drug for severe and lethal infections," Imai says.

Explore further: Lipid blocks influenza infection

More information: Cell, Morita et al.: "The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza." dx.doi.org/10.1016/j.cell.2013.02.027

Related Stories

Lipid blocks influenza infection

November 9, 2011
A natural lipid in the fluid lining the lungs inhibits influenza infections in both cell cultures and mouse models, according to researchers at National Jewish Health. These findings, combined with previous studies demonstrating ...

Antiviral lipid earns patent: Lipids in lung can inhibit RSV and influenza infections

March 5, 2013
Dennis Voelker, PhD, professor of medicine at National Jewish Health, has been awarded a U.S. patent (#8,367,643) for various lipids and related compounds that can inhibit inflammation and infection in the lungs, especially ...

Reconstructed 1918 influenza virus has yielded key insights, scientists say

September 11, 2012
The genetic sequencing and reconstruction of the 1918 influenza virus that killed 50 million people worldwide have advanced scientists' understanding of influenza biology and yielded important information on how to prevent ...

2009 H1N1 pandemic flu more damaging to lungs, opens opportunities for bacterial infection

September 19, 2011
Many of the people who died from the new strain of H1N1 influenza that broke out in 2009 were suffering from another infection as well: pneumonia. A new study to be published Tuesday, September 20 in the online journal mBio ...

H5N1 virus targets pulmonary endothelial cells

January 20, 2012
The H5N1 virus has killed roughly 60 percent of humans infected, a mortality rate which is orders of magnitude higher than that of seasonal influenza virus. Many victims of the former fall heir to acute respiratory distress  ...

Recommended for you

Magnetically applied MicroRNAs could one day help relieve constipation

January 17, 2018
Constipation is an underestimated and debilitating medical issue related to the opioid epidemic. As a growing concern, researchers look to new tools to help patients with this side effect of opioid use and aging.

Researchers devise decoy molecule to block pain where it starts

January 16, 2018
For anyone who has accidentally injured themselves, Dr. Zachary Campbell not only sympathizes, he's developing new ways to blunt pain.

Scientists unleash power of genetic data to identify disease risk

January 16, 2018
Massive banks of genetic information are being harnessed to shed new light on modifiable health risks that underlie common diseases.

Blood-vessel-on-a-chip provides insight into new anti-inflammatory drug candidate

January 15, 2018
One of the most important and fraught processes in the human body is inflammation. Inflammatory responses to injury or disease are crucial for recruiting the immune system to help the body heal, but inflammation can also ...

Molecule produced by fat cells reduces obesity and diabetes in mice

January 15, 2018
UC San Francisco researchers have discovered a new biological pathway in fat cells that could explain why some people with obesity are at high risk for metabolic diseases such as type 2 diabetes. The new findings—demonstrated ...

Obese fat becomes inflamed and scarred, which may make weight loss harder

January 12, 2018
The fat of obese people becomes distressed, scarred and inflamed, which can make weight loss more difficult, research at the University of Exeter has found.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.